Literature DB >> 25838104

Periostin in the bronchial lavage fluid of asthma patients.

Yutaka Nakamura1, Hiromi Nagashima1, Shoichiro Ohta2, Junya Ono3, Kohei Yamauchi4, Kenji Izuhara5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25838104     DOI： 10.1016/j.alit.2015.01.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  4 in total

1.  Periostin in Exhaled Breath Condensate and in Serum of Asthmatic Patients: Relationship to Upper and Lower Airway Disease.

Authors:  Aleksandra Wardzyńska; Joanna S Makowska; Małgorzata Pawełczyk; Aleksandra Piechota-Polańczyk; Marcin Kurowski; Marek L Kowalski
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

Review 2.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

3.  Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma.

Authors:  Yutaka Nakamura; Aki Sugano; Mika Ohta; Yutaka Takaoka
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

4.  Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin.

Authors:  Karina T Barretto; Calvin M Swanson; Christopher L Nguyen; Douglas S Annis; Stephane J Esnault; Deane F Mosher; Mats W Johansson
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.